Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund and Insider Trading News: Adage Capital Partners, Goosehead Insurance Inc (GSHD), Patrick Industries, Inc. (PATK), Weyland Tech Inc (WEYL), and More

Insider Selling: Patrick Industries, Inc. (PATK) Director Sells 222,347 Shares of Stock (ModernReaders.com)
Patrick Industries, Inc. (NASDAQ:PATK) Director Jeffrey L. Et Al Gendell sold 222,347 shares of the business’s stock in a transaction dated Monday, December 17th. The shares were sold at an average price of $30.34, for a total value of $6,746,007.98. The transaction was disclosed in a filing with the SEC.

Insider Buying: Weyland Tech Inc (WEYL) CEO Acquires 50,000 Shares of Stock (MareaInformativa.com)
Weyland Tech Inc (OTCMKTS:WEYL) CEO Brent Suen acquired 50,000 shares of Weyland Tech stock in a transaction that occurred on Friday, November 30th. The shares were purchased at an average cost of $1.15 per share, with a total value of $57,500.00. The transaction was disclosed in a filing with the Securities & Exchange Commission.

Insider Selling: Goosehead Insurance Inc (GSHD) Insider Sells 49,081 Shares of Stock (PressOracle.com)
Goosehead Insurance Inc (NASDAQ:GSHD) insider & Robyn Jones Descendants Mark sold 49,081 shares of the stock in a transaction that occurred on Friday, December 14th. The stock was sold at an average price of $27.21, for a total transaction of $1,335,494.01. The transaction was disclosed in a legal filing with the SEC.

Insider Selling: Fate Therapeutics Inc (NASDAQ:FATE) Director Sells 17,788 Shares of Stock (FairFieldCurrent.com)
Fate Therapeutics Inc (NASDAQ:FATE) Director Amir Nashat sold 17,788 shares of the stock in a transaction on Thursday, December 13th. The stock was sold at an average price of $16.67, for a total transaction of $296,525.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Insider Selling: USG Co. (USG) Insider Sells 52,063 Shares of Stock (PressOracle.com)
USG Co. (NYSE:USG) insider Brian J. Cook sold 52,063 shares of the company’s stock in a transaction dated Monday, December 3rd. The shares were sold at an average price of $43.04, for a total transaction of $2,240,791.52. Following the sale, the insider now owns 66,629 shares of the company’s stock, valued at $2,867,712.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Insider Selling: Walmart Inc (WMT) Director Sells 298,726 Shares of Stock (FairFieldCurrent.com)
Walmart Inc (NYSE:WMT) Director S Robson Walton sold 298,726 shares of the company’s stock in a transaction that occurred on Friday, December 14th. The stock was sold at an average price of $92.24, for a total value of $27,554,486.24. Following the transaction, the director now owns 3,347,254 shares in the company, valued at approximately $308,750,708.96. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...